文献速递胸部肿瘤放疗放疗物理与技术

4DCT通气成像用于肺癌术前风险评估的前瞻性评估:LIME试验结果

Prospective Evaluation of Novel 4DCT-Ventilation Imaging for Preoperative Risk Assessment in Lung Cancer: Results of the LIME Trial.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2026-07-30

LIME试验前瞻性纳入65例I-IIIa期肺癌拟行解剖性肺切除患者,比较基于4DCT通气成像计算的术后预测肺功能(PPO PFT)与常规方法的一致性。基于4DCT通气的预测符合率(CCC)为FEV1 91%、FVC 89%、DLCO 88%,达到主要终点;在肺功能不均质患者中4DCT方法表现更优。结论支持进一步开展干预性试验以指导手术决策。

要点

  • 4DCT通气预测PPO PFT的CCC达FEV1 91%、FVC 89%、DLCO 88%,满足主要终点。
  • 常规方法CCC与4DCT相近,但肺功能不均质患者中4DCT预测更优。
  • 结果支持开展干预性试验,用4DCT通气前瞻性指导肺癌手术决策。

核心结论

  • LIME试验达到主要终点,基于4DCT通气的PPO PFT预测准确。
  • 数据支持进一步开展干预性试验,用4DCT通气前瞻性指导肺癌手术决策。

研究设计与样本

  • 前瞻性临床试验,2018至2021年纳入65例I-IIIa期肺癌拟行解剖性肺切除患者,36例可评估。
  • 患者术前及术后3个月接受肺功能检查(PFT)和4DCT成像,用验证过的图像处理技术生成4DCT通气图像。
  • 通过将术前PFT按手术范围内4DCT通气比例缩放计算基于4DCT通气的PPO PFT,并与标准护理方法计算的常规PPO PFT比较。
  • 用一致性相关系数(CCC)比较PPO PFT与3项PFT指标:第一秒用力呼气容积(FEV1)、用力肺活量(FVC)、肺一氧化碳弥散量(DLCO)。
  • 主要假设为基于4DCT通气预测的CCC≥85%。

主要发现

  • 基于4DCT通气的CCC为FEV1 91%、FVC 89%、DLCO 88%,达到主要终点。
  • 常规方法的CCC与4DCT方法相当,但在肺功能不均质患者中4DCT似乎表现更好。

关键数值与推荐

  • 主要终点为基于4DCT通气预测的CCC≥85%。
  • 基于4DCT通气的CCC:FEV1 91%、FVC 89%、DLCO 88%。

临床怎么用

  • 4DCT通气成像可在术前更准确地预测术后肺功能,尤其适用于肺功能不均质患者。
  • 目前数据支持进一步开展干预性试验,暂不直接改变手术决策。

局限性

  • 65例同意研究中仅36例可评估。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSES: Surgery is the primary treatment for early-stage lung cancer. Patients with poor preoperative lung function are at increased risk of pulmonary complications after anatomic lung resection. Surgeons determine candidacy for lung resection using pulmonary function tests (PFTs), calculating predicted postoperative PFTs (PPO PFTs) by estimating the volume of lung to be resected. Conventional PPO PFT calculations assume homogeneous lung function, which can be inaccurate. Four-dimensional computed tomography (4DCT)-ventilation is a novel imaging modality developed in radiation oncology that uses 4DCT data to calculate lung function maps. This study reports the primary outcomes of the LIME trial, a prospective clinical trial comparing 4DCT-ventilation-based PPO PFTs to conventionally measured PPO lung function. METHODS AND MATERIALS: The trial enrolled patients with stage I-IIIa lung cancer undergoing evaluation for anatomic lung resection. Patients underwent PFTs and 4DCT imaging before and 3 months after surgery. Validated image processing techniques generated 4DCT-ventilation images using the preoperative 4DCT. We calculated 4DCT-ventilation-based PPO PFTs by scaling preoperative PFTs by the 4DCT-ventilation in the surgical volume and conventional PPO PFTs following standard-of-care methods. Concordance correlation coefficients (CCCs) compared PPO PFTs with PPO PFTs for 3 PFT measures: forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), and diffusing capacity of the lungs for carbon monoxide (DLCO). The primary hypothesis was a CCC ≥85% for 4DCT-ventilation-based predictions. RESULTS: From 2018 to 2021, 65 patients consented to the study, with 36 considered evaluable. The 4DCT-ventilation-based CCCs were 91% (FEV1), 89% (FVC), and 88% (DLCO), meeting the primary endpoint. Conventional CCCs were comparable, although 4DCT appeared to perform better than the conventional approach in patients with heterogeneous lung function. CONCLUSIONS: The trial met the primary endpoint with accurate 4DCT-ventilation-based prediction. The data support further investigation in an interventional trial using 4DCT-ventilation to prospectively guide surgical decision-making in lung cancer treatment.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Wilson LJ, Castillo R, Castillo E, et al. Prospective Evaluation of Novel 4DCT-Ventilation Imaging for Preoperative Risk Assessment in Lung Cancer: Results of the LIME Trial. Int J Radiat Oncol Biol Phys. 2026. PMID: 42532440. doi:10.1016/j.ijrobp.2026.07.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。